Opening its latest reports…Reading every line of the four statements…Putting it into plain words…
Opening its latest reports…Reading every line of the four statements…Putting it into plain words…
GDRXGoodRx Holdings, Inc.
Every company that sells shares in the US files four statements with the SEC. Together they show whether GoodRx Holdings made money, what it owns and owes, where its cash went, and what changed for its shareholders. Below is every line exactly as GoodRx Holdings filed it, with what each one means in plain English.
As filed with the SEC on Feb 26, 2026 · the full report · SEC's figures viewer
Income statement · also called the statement of operations, statement of earnings or profit and loss
Read it from the top down. It starts with everything customers paid (sales), takes away the cost of making what was sold, then the costs of running the company, then interest and tax. What is left at the bottom is profit (net income), the part that belongs to shareholders. It covers a stretch of time: a year, or a quarter.
Out of every $100 of sales
| Line (tap for what it means) | 12 months to Dec 31, 2025 | 12 months to Dec 31, 2024 | 12 months to Dec 31, 2023 |
|---|---|---|---|
| $796.9M▲ 0.6% | $792.3M | $750.3M | |
| Costs and operating expenses | |||
| $57.6M▲ 19% | $48.2M | $66.9M | |
| $121.0M▼ 2.2% | $123.7M | $135.8M | |
| $331.6M▼ 9.7% | $367.1M | $341.3M | |
| $114.0M▼ 3.3% | $117.9M | $125.5M | |
| $85.2M▲ 23% | $69.5M | $107.7M | |
| $709.4M▼ 2.4% | $726.5M | $777.3M | |
| $87.5M▲ 33% | $65.8M | −$27.0M | |
| Other expense, net | |||
| $718.0K | −$2.7M | −$4.0M | |
| $0▲ 100% | −$2.1M | $0 | |
| $10.9M▼ 53% | $23.3M | $32.2M | |
| −$42.6M▲ 19% | −$52.9M | −$56.7M | |
| −$31.0M▲ 10.0% | −$34.4M | −$28.6M | |
| $56.5M▲ 80% | $31.5M | −$55.6M | |
| −$26.1M▼ 73% | −$15.1M | $46.7M | |
| $30.4M▲ 86% | $16.4M | −$8.9M | |
| Earnings (loss) per share | |||
| $0.09▲ 125% | $0.04 | −$0.02 | |
| $0.09▲ 125% | $0.04 | −$0.02 | |
| Weighted average shares used in computing earnings (loss) per share | |||
| 356.3M shares▼ 7.6% | 385.7M shares | 410.3M shares | |
| 357.0M shares▼ 9.0% | 392.2M shares | 410.3M shares | |
| Cost of revenue | |||
|---|---|---|---|
| Pay given in shares (stock-based compensation) (Total stock-based compensation) | $357.0K | $320.0K | $610.0K |
| Product development and technology | |||
| Pay given in shares (stock-based compensation) (Total stock-based compensation) | $22.5M | $24.6M | $30.1M |
| Sales and marketing | |||
| Pay given in shares (stock-based compensation) (Total stock-based compensation) | $20.2M | $33.4M | $20.3M |
| General and administrative | |||
| Pay given in shares (stock-based compensation) (Total stock-based compensation) | $33.5M | $40.7M | $53.8M |
Every line as the company filed it (USD ($), shares in Thousands, $ in Thousands), shown in full dollars. See this statement on SEC.